WHO:	Rhonda Greenapple, MSPH, President of Reimbursement Intelligence and Warren Dodge, President of Oncology Metrics
WHAT:	ASCO Breakfast Session
WHERE:	The Matterhorn Room, located on the 42nd Floor., Swissotel Chicago, 323 E. Wacker Drive, Chicago, IL 60601
WHEN:	Monday, June 2nd, 6:30 a.m. – 7:30 a.m.

Until recently, oncology treatment decisions were exempt from health plan interference. With multiple early stage products entering the same category, premium pricing will be a challenge as payors increase their management of oncology products and costs shift for oncology patients.
Reimbursement Intelligence and Oncology Metrics will be holding a breakfast session during the American Society of Clinical Oncology’s (ASCO) Annual Conference in Chicago on Monday, June 2nd from 6:30 a.m. – 7:30 a.m. discussing how changes will impact commercialization for a product in development.
The breakfast will be presented by Rhonda Greenapple, MSPH, President of Reimbursement Intelligence and Warren Dodge, President of Oncology Metrics. Reimbursement Intelligence is a reimbursement consulting company and an informed source for reimbursement trends, news and strategies, tailored to the biotech and pharmaceutical industry.
Oncology Metrics is a leader in measuring and adopting best practices for community oncology centers. This includes helping their members to improve operational and financial performance.
Questions that will be answered include: